Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -21.40%56.36M | -54.26%46.19M | 132.60%44.53M | 89.89%233.69M | -7.01%45.33M | 86.19%71.7M | 207.85%100.97M | 200.83%19.15M | -11.09%123.07M | 38.44%48.74M |
| Cost of revenue | -17.72%51.51M | -27.55%42.24M | 109.00%39.13M | 112.59%176.9M | 62.61M | 58.3M | 18.72M | 93.23%83.21M | ||
| Gross profit | -46.69%4.84M | -90.74%3.95M | 1,177.07%5.4M | 42.49%56.79M | 9.09M | 42.67M | 423K | -58.20%39.86M | ||
| Operating expense | 11.45%6.03M | -12.40%6.02M | 44.99%9.27M | -88.49%32.76M | -85.07%46.59M | -85.61%5.41M | -54.89%6.87M | 1.35%6.4M | 182.55%284.64M | 1,289.45%312.11M |
| Staff costs | ---- | ---- | ---- | 11.47%20.55M | ---- | ---- | ---- | ---- | -66.98%18.43M | ---- |
| Selling and administrative expenses | ---- | ---- | ---- | 1.49%544K | ---- | ---- | ---- | ---- | 3.68%536K | ---- |
| -General and administrative expense | ---- | ---- | ---- | 1.49%544K | ---- | ---- | ---- | ---- | 3.68%536K | ---- |
| Depreciation and amortization | ---- | ---- | ---- | -0.99%3.59M | ---- | ---- | ---- | ---- | 16.01%3.62M | ---- |
| -Depreciation | ---- | ---- | ---- | -0.99%3.59M | ---- | ---- | ---- | ---- | 16.01%3.62M | ---- |
| Rent and land expenses | ---- | ---- | ---- | 201.92%314K | ---- | ---- | ---- | ---- | -92.24%104K | ---- |
| Other operating expenses | 11.45%6.03M | -12.40%6.02M | 44.99%9.27M | -97.04%7.76M | -85.07%46.59M | -85.61%5.41M | -54.89%6.87M | 1.35%6.4M | 555.90%261.94M | 914.07%312.11M |
| Operating profit | -132.40%-1.19M | -105.76%-2.06M | 35.20%-3.87M | 109.82%24.04M | 99.52%-1.27M | 319.77%3.67M | 103.76%35.8M | -11,159.26%-5.97M | -4,443.00%-244.78M | -768.75%-263.37M |
| Net non-operating interest income (expenses) | 279.72%1.07M | 452.33%303K | 269.87%265K | 101.57%332K | 104.95%292K | 105.43%281K | 98.31%-86K | 96.91%-156K | -18.17%-21.21M | -17.20%-5.9M |
| Non-operating interest income | 143.27%1.19M | 131.68%468K | 214.08%446K | 482.35%1.39M | 203.30%552K | 2,350.00%490K | 1,088.24%202K | 647.37%142K | 266.15%238K | 970.59%182K |
| Non-operating interest expense | -40.19%125K | -42.71%165K | -39.26%181K | -95.09%1.05M | -95.73%260K | -95.97%209K | -94.37%288K | -94.12%298K | 19.07%21.45M | 20.41%6.08M |
| Net investment income | 233.11%4.47M | -745.77%-3.36M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 0 | -312.79%-14.82M | 0 | -14.82M | -695K | 695K | 6.97M | 6.97M |
| Income from associates and other participating interests | 129.51%1.08M | 88.39%-72K | -1.67%-1.16M | -49.24%1.43M | -60.07%2.71M | 544.34%471K | 79.53%-620K | -34.08%-1.14M | -36.29%2.81M | 20.53%6.79M |
| Special income (charges) | 455.00%284K | 0 | -101.08%-80K | 0 | ||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -49.02%26K | ---- |
| Less:Other special charges | ---- | ---- | ---- | -625.93%-284K | ---- | ---- | ---- | ---- | 100.73%54K | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | --0 |
| Other non-operating income (expenses) | 3.02%3.45M | 0.00%3.35M | ||||||||
| Income before tax | 109.22%958K | -105.33%-1.83M | 27.53%-4.76M | 107.48%19.18M | 100.68%1.74M | -136.17%-10.4M | 264.25%34.4M | -12.52%-6.57M | -3,238.62%-256.31M | -1,283.98%-255.51M |
| Income tax | -49.65%782K | -97.31%249K | 341.41%437K | 20.65%11.61M | -77.92%719K | 18.19%1.55M | 110.43%9.24M | -85.05%99K | -21.42%9.62M | -59.38%3.26M |
| Net income | 101.47%176K | -108.27%-2.08M | 22.06%-5.2M | 102.85%7.57M | 100.39%1.02M | -109.04%-11.95M | 397.88%25.16M | -2.58%-6.67M | -1,234.72%-265.93M | -877.22%-258.77M |
| Net income continuous operations | 101.47%176K | -108.27%-2.08M | 22.06%-5.2M | 102.85%7.57M | 100.39%1.02M | -109.04%-11.95M | 397.88%25.16M | -2.58%-6.67M | -1,234.72%-265.93M | -877.22%-258.77M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Net income attributable to the company | 101.47%176K | -108.27%-2.08M | 22.06%-5.2M | 102.85%7.57M | 100.39%1.02M | -109.04%-11.95M | 397.88%25.16M | -2.58%-6.67M | -1,234.72%-265.93M | -877.22%-258.77M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 101.47%176K | -108.27%-2.08M | 22.06%-5.2M | 102.85%7.57M | 100.39%1.02M | -109.04%-11.95M | 397.88%25.16M | -2.58%-6.67M | -1,234.72%-265.93M | -877.22%-258.77M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 101.42%0.0003 | -108.30%-0.0037 | 22.18%-0.0207 | 101.15%0.0122 | 100.17%0.0018 | 7.83%-0.0212 | 119.70%0.0446 | -1.53%-0.0266 | -1,220.82%-1.0593 | -866.89%-1.0307 |
| Diluted earnings per share | 101.42%0.0003 | -108.30%-0.0037 | 22.18%-0.0207 | 101.05%0.0111 | 100.17%0.0018 | 7.83%-0.0212 | 119.70%0.0446 | -1.53%-0.0266 | -1,220.82%-1.0593 | -866.89%-1.0307 |
| Dividend per share | 0 | 0 | 0 | 0.03 | 0.03 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.